References
- Carrington CB, Addington WW, GofT AM et al. Chronic eosinophilic pneumonia. N Engl J Med. 1969; 280: 787–98.
- Cushid MJ, David CD, West BC, WolIT SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine. 1975; 54: 1–28.
- Parillo JE, Fauci AS, Sheldon SM. Therapy of the hypereosinophilic syndrome. Ann Intern Med. 1978; 89: 167–72.
- Parillo JE, Borer JS, Henry WL, Wolff SM, Fauci AS. The cardiovascular manifestations of the hypereosinophilic syndrome. Am J Med. 1979; 67: 572–82.
- Kazmierowski JA, Cushid MJ, Parillo JE, Fauci AS, Wolff SM. Dermatologic manifestations of the hypereosinophilic syndrome. Arch Dermatol. 1978; 1 14: 531–5.
- Spry C. Hypereosinophilic syndromes, in: Postgraduate course in Haematology 1981, Hammersmith Hospital, London, 31–2.
- Pomerance A, Davies MJ. Pathology of the heart, p. 37, ch. I. Blackwell Scientific Publications, Oxford, 1975.
- Olsen EGJ. Endomyocardial fibrosis and Loffler’s endocarditis parietalis fibroplastica. Postgraduate Medical J. 1977; 53: 538–40.
- Brockington IF, Olsen EGJ. Loffier’s endocarditis and Davies’ endomyocardial fibrosis. Am Heart J. 1973; 85: 308–22.
- Davies JNP. Endocardial fibrosis in africans. East Afric Med J. 1948; 25: 10–4.
- Weiss-Carmine S. Die Endocarditis parietalis fibroplastica mit Bluteosinophilie (Loffler) und ihre Stellung in Rahmen der Parietalendokardfibrosen Schweiz Mediz Wschr. 1957; 26: 888–97.
- Buterworth A, David JR. Eosinophil function. N Engl J Med. 1981; 304: 154–6.
- David JR. Vadas MA, Butterworth AE et al. Enhanced helminthotoxic capacity of eosinophils from patients with eosinophilia. N Engl J Med. 1980; 303: 1 147–52.
- Anwar ARE, Smithers SR, Kay AB. Killing of Schistosomula of Schistosoma mansoni coated with antibody and/or complement by human leucocytes in vitro: requirement for complement in preferential killing by eosinophils. J Immunol. 1979; 122: 628–37.
- Parillo JE, Fauci AS. Human eosinophils. Purification and cytotoxic capability of eosinophils from patients with the hypereosinophilic syndrome. Blood. 1978; 51: 457–73.
- Parillo JE, Lawley TJ, Frank MM, Kaplan AP, Fauci AS. Immunologic reactivity in the hype reosinophilic syndrome. J Allerg Clin Immunol. 1979; 64: 113–21.
- Flaum MA, Schooley RT, Fauci AS, Gralnick HR. A clinicopathologic correlation of the idiopathic hypereosinophilic syndrome. I. Hematologic manifestations. Blood. 1981; 58: 101220.
- Van Slijck EJ, Adamson TC. Acute hypereosinophilic syndrome. Successful treatment with vincristine, cytarabine and prednisone. JAMA. 1979; 242: 175–6.
- Ikaheimo MJ, Karkola PJ, Takkunen JT. Surgical treatment of Loffier’s eosinophilic endocarditis. Brit Heart J. 1981; 45: 729–32.
- Ellman L, Miller, Rappeport J. Leukopheresis therapy of a hypereosinophilic disorder. JAMA. 1974; 230: 1004–5.